Downregulation of caspase‐9 is a frequent event in patients with stage II colorectal cancer and correlates with poor clinical outcome
暂无分享,去创建一个
[1] Bin Zhou,et al. Clinicopathological Significance of Caspase-8 and Caspase-10 Expression in Rectal Cancer , 2008, Oncology.
[2] J. Beaulieu,et al. Normalizing genes for quantitative RT-PCR in differentiating human intestinal epithelial cells and adenocarcinomas of the colon. , 2006, American journal of physiology. Gastrointestinal and liver physiology.
[3] J. Ferlay,et al. Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.
[4] H. Grönberg,et al. Adjuvant chemotherapy in colorectal cancer: A joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group , 2005, Acta oncologica.
[5] R. Labianca,et al. Adjuvant therapy for stage II colon cancer: an elephant in the living room? , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.
[6] S. Cha,et al. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] L. Rorke,et al. Loss of caspase-8 protein expression correlates with unfavorable survival outcome in childhood medulloblastoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[8] I. Yang,et al. Regulation of caspase expression and apoptosis by adenomatous polyposis coli. , 2003, Cancer research.
[9] Christopher F. Martin,et al. Nonsteroidal anti-inflammatory drugs, apoptosis, and colorectal adenomas. , 2002, Gastroenterology.
[10] C. Begg,et al. Adjuvant chemotherapy use for Medicare beneficiaries with stage II colon cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] G. Horgan,et al. Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR , 2002 .
[12] Gen Sheng Wu,et al. Caspase 9 is required for p53-dependent apoptosis and chemosensitivity in a human ovarian cancer cell line , 2002, Oncogene.
[13] D. Waxman,et al. Cyclophosphamide induces caspase 9-dependent apoptosis in 9L tumor cells. , 2001, Molecular pharmacology.
[14] J. Bergh,et al. How apoptosis is regulated, and what goes wrong in cancer , 2001, BMJ : British Medical Journal.
[15] L. Denner,et al. 3-m-bromoacetylamino benzoic acid ethyl ester: a new cancericidal agent that activates the apoptotic pathway through caspase-9. , 2000, Biochemical pharmacology.
[16] S. Lam,et al. Aspirin induced apoptosis in gastric cancer cells. , 1999, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[17] H. Rockette,et al. Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04) , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] Martin Raff,et al. Cell suicide for beginners , 1998, Nature.
[19] Y. Lazebnik,et al. Oncogene-dependent apoptosis is mediated by caspase-9. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[20] Y. Lazebnik,et al. Caspases: enemies within. , 1998, Science.
[21] M. Loda,et al. The DCC protein and prognosis in colorectal cancer. , 1996, The New England journal of medicine.
[22] Road,et al. The Spread of Rectal Cancer and its Effect on Prognosis , 1958, British Journal of Cancer.
[23] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[24] A. Borkowski,et al. Human Prostate Cancer Loss of Caspase-1 and Caspase-3 Protein Expression in Updated Version , 2001 .
[25] W. Bodmer,et al. Somatic cell genetics and cancer. , 1988, Cancer surveys.